Atux Iskay Group, LLc
Atux Iskay Group LLC is a Plainsboro, New Jersey biotech company developing small molecule modulators of the tumor suppressor Protein Phosphatase 2A (PP2A). The company focuses on oncology, neurodegenerative disease, and respiratory disease, leveraging senotherapeutic approaches to normalize PP2A function. Atux Iskay has received SBIR funding from the NIH and NJEDA.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
